Reperfusion Therapy in ST-segment Elevation Myocardial Infarction – Data from a Pilot Registry of Myocardial Infarction

Abstrakt

Methods: A total of 744 consecutive patients with STEMI from years 2003–2006 were included in the study. Also, data on their demographics and reperfusion strategy were collected. An assessed clinical outcome was in-hospital mortality. Results: The mean age of STEMI patients was 66.9 +/- 2.6 years. The vast majority were men (62.4%). A total of 68.6% STEMI patients received primary reperfusion treatment, 97.0% of them were referred for PPCI and 3.6% were treated with fibrinolytic therapy. Women and elderly patients were less likely to receive reperfusion therapy. The in-hospital mortality was 11.3% for all STEMI patients; 3.5% in reperfused and 25.7% in non-reperfused group (p < 0.001). When adjusting for age, the effect of reperfusion therapy remained significant. Conclusions: In-hospital mortality was significantly reduced in a subgroup of patients who underwent primary reperfusion treatment (PPCI or fibrinolytic therapy).

Kategorie a štítky

  • Článek v odborném periodiku